Validation of a comorbidity index for use in obstetric patients: A nationwide cohort study

被引:21
|
作者
Bliddal, Mette [1 ,2 ]
Moller, Soren [1 ,2 ]
Vinter, Christina A. [1 ,3 ]
Rubin, Katrine H. [1 ,2 ]
Gagne, Joshua J. [4 ,5 ]
Pottegard, Anton [6 ]
机构
[1] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[2] Odense Univ Hosp, OPEN Open Patient Data Explorat Network, JB Winslow Vej 9a, DK-5000 Odense C, Denmark
[3] Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark
[4] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA
[5] Harvard Med Sch, Boston, MA 02115 USA
[6] Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol, Odense, Denmark
关键词
adverse maternal outcomes; comorbidity; obstetric comorbidity index; prediction; reproduction; validation; DANISH; DIAGNOSES; REGISTRY; RISK;
D O I
10.1111/aogs.13749
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction A previously developed Obstetric Comorbidity Index has been validated in highly selected cohorts. Validation of the index in an unselected population as well as in other health registers is, however, of high importance to determine external validity. Material and methods Using nationwide registers, we formed a nationwide cohort including completed pregnancies (both live- and stillborn) in Denmark from 2000 through 2014. Maternal age and 20 comorbid conditions were assessed and weighted. Outcomes were maternal end-organ injury or death within 30 days postpartum. The index's predictive and discriminative ability was estimated by Brier score and the area under the receiver operating characteristic curve (AUC), respectively. Logistic regression analysis was used to estimate odds ratios (OR) with 95% confidence interval (CI). Results In 876 496 completed pregnancies by 527 079 women, 1.40% (n = 12 314) experienced an outcome. The majority of women (64.1%) did not have any record of a condition included in the index and only 0.3% (n = 3044) had a score >6. The incidence of an outcome increased with increasing comorbidity score from 0.9% (95% CI 0.8-0.9) in women scoring 0% to 10.4% (95% CI 7.6-13.9) in women scoring 9-10. Compared with women scoring 0, a score of 1-2 yielded an OR of 2.34 (95% CI 2.25-2.44), 3-4 an OR of 5.16 (95% CI 4.81-5.54), 5-6 an OR of 4.84 (95% CI 4.31-5.44), and 8-9 an OR of 7.97 (95% CI 6.54-9.72) for experiencing the outcome. The index had a Brier score of 0.01 and an AUC of 0.64. Conclusions Despite potential weaknesses in the outcome definition, the Obstetric Comorbidity Index showed a moderate ability to discriminate and predict end-organ injury and death in a nationwide cohort in Denmark, in accordance with previous findings. These results suggest that the index may be a useful tool to control for confounding in health research and clinically to identify women at high risk for adverse maternal outcomes.
引用
收藏
页码:399 / 405
页数:7
相关论文
共 50 条
  • [1] Validation of a comorbidity index for use in obstetric patients: A Nationwide cohort study
    Bliddal, Mette
    Moller, Soren
    Vinter, Christina
    Rubin, Katrine
    Gagne, Joshua
    Pottegard, Anton
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 359 - 359
  • [2] Development of a Comorbidity Index for Use in Obstetric Patients
    不详
    OBSTETRICS AND GYNECOLOGY, 2013, 122 (05): : 957 - 965
  • [3] Validation of an obstetric comorbidity index in an external population
    Metcalfe, A.
    Lix, L. M.
    Johnson, J-A
    Currie, G.
    Lyon, A. W.
    Bernier, F.
    Tough, S. C.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2015, 122 (13) : 1748 - 1755
  • [4] Risk of comorbidity in patients with multiple sclerosis: a nationwide cohort study in Sweden
    Piehl, F.
    Castelo-Branco, A.
    Chiesa, F.
    Conte, S.
    Rosenlund, M.
    Lee, S.
    Minton, N.
    Niemcryk, S.
    Lindholm, A.
    Montgomery, S.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 102 - 102
  • [5] Development and validation of the Korea Dementia Comorbidity Index (KDCI): A nationwide population-based cohort study from 2002 to 2013
    Kim, Jae-Hyun
    Yoo, Ki-Bong
    Lee, Yunhwan
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2017, 72 : 195 - 200
  • [6] Validation of the Washington University head and neck comorbidity index in a cohort of older patients
    Sanabria, Alvaro
    Carvalho, Andre Lopes
    Vartanian, Jose Guilherme
    Magrin, Jose
    Ikeda, Mauro Kasuo
    Kowalski, Luiz Paulo
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2008, 134 (06) : 603 - 607
  • [7] Validation of a modified obstetric comorbidity index for prediction of postpartum adverse events including fetal morbidity - a retrospective cohort study from Qatar
    Chaalan, Fouad
    Minisha, Fathima
    Zaidi, Zehra
    Babekar, Alaa
    Saleh, Huda Abullah Hussain
    Shurbak, Zeena Saeed Bu
    Al Baloushi, Mariam
    Alnaama, Alaa
    Ahmed, Husham
    Babarinsa, Isaac
    Dewik, Nader Al
    Pallivalapila, Abdulrouf
    Olagundoye, Victor
    Farrell, Thomas
    BMC PREGNANCY AND CHILDBIRTH, 2024, 24 (01)
  • [8] Prospective clinical validation of the obstetric comorbidity index for maternal risk assessment
    Easter, Sarah Rae
    Sweeney, Valerie
    Manganaro, Karen
    Lassey, Sarah C.
    Bateman, Brian T.
    Robinson, Julian N.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (01) : S198 - S199
  • [9] VALIDATION OF THE UPDATED CHARLSON COMORBIDITY INDEX (CCI) FOR USE IN PATIENTS WITH DIABETES OR ASTHMA: A COMPARISON STUDY
    Cheng, L., I
    Rascati, K., I
    VALUE IN HEALTH, 2011, 14 (07) : A486 - A486
  • [10] Development and Validation of an Obstetric Comorbidity Risk Score for Clinical Use
    Ruppel, Halley
    Liu, Vincent X.
    Kipnis, Patricia
    Hedderson, Monique M.
    Greenberg, Mara
    Forquer, Heather
    Lawson, Brian
    Escobar, Gabriel J.
    WOMENS HEALTH REPORTS, 2021, 2 (01): : 507 - 515